Loading...

Progyny, Inc.

PGNYNASDAQ
HealthcareMedical - Healthcare Information Services
$20.52
$-0.37(-1.77%)

Progyny, Inc. (PGNY) Stock Overview

Explore Progyny, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
7.22%
7.22%
Profit Growth
$0.61
12.41%
EPS Growth
$0.61
9.23%
Operating Margin
6.03%
8.48%
ROE
11.80%
12.41%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$18.00
Average$24.00
High$36.00

Company Profile

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

CEO

Mr. Peter Anevski CPA

Employees

675

Headquarters

1359 Broadway, New York, NY

Founded

2019

Frequently Asked Questions